MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Trevena, Inc. (NASDAQ: TRVN)
Organization & Developments: Trevena
Parents
Trevena, Inc. (NASDAQ: TRVN)
Children
*Trevena is a clinical stage biopharmaceutical company involved in the discovery and development of G-protein coupled receptors biased ligands
*Trevena, Inc. (NASDAQ: TRVN) is a biopharmaceutical company dedicated to the development and commercialization of GPCR selective ligands for the treatment of CNS conditions.
2019: FDA Minutes To Bring Trevena Back To Life?_seekingalpha.com
2019: Trevena: At Phase 3 Of Development, But Uncertain Times Continue_seekingalpha.com
2021: Trevena: Taking A Systematic Approach With A Speculative Investment
2024: Trevena to be delisted from Nasdaq over equity shortfall
Jumps
*Key People: Trevena
Finance & Acquisitions: Trevena